Figure 5.
Cytoprotective effects of GP-17 on Ox-LDL-induced cytotoxicity in HUVECs. (A) HUVECs were treated with Ox-LDL at different concentrations for 24 h. Cell viability was measured by MTT assays; (B) Cell viability of HUVECs incubated with different concentrations of GP-17 for 12 h; (C) Incubation with GP-17 significantly lowered Ox-LDL-induced cell injury. Cell viability was measured by MTT assays. The values are expressed as the mean ± S.E.M. from three independent experiments. ### p < 0.001 vs. Control; ** p < 0.01; *** p < 0.001 vs. Model. MTT, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide.